RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value: $1.305B (100.0% shares, 0.0% debt)

Holdings (31)

WVE WAVE LIFE SCIENCES LTD 23.1%
Value $301M Shares 7,512,049 Share Price $40.10 * Est. Cost/Share $16.44 Unrealized @ Report Date +155.7%
ASND ASCENDIS PHARMA A S 21.2%
Value $277M Shares 4,240,536 Share Price $65.40 Est. Cost/Share $17.96 Unrealized @ Report Date —
— AVEXIS INC 9.7%
Value $127M Shares 1,028,289 Share Price $123.58 Est. Cost/Share $31.86 Unrealized @ Report Date —
— MYOVANT SCIENCES LTD 4.6%
Value $60.2M Shares 2,830,455 Share Price $21.27 Est. Cost/Share $12.11 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 4.4%
Value $56.88M Shares 353,133 Share Price $161.07 Est. Cost/Share $164.71 Unrealized @ Report Date —
IFRX INFLARX NV 3.6%
Value $46.74M Shares 1,620,653 Share Price $28.84 * Est. Cost/Share $17.97 Unrealized @ Report Date +46.7%
— ZOGENIX INC 3.5%
Value $45.87M Shares 1,145,268 Share Price $40.05 Est. Cost/Share $16.89 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 2.9%
Value $37.6M Shares 3,933,489 Share Price $9.56 Est. Cost/Share $18.43 Unrealized @ Report Date —
— SCPHARMACEUTICALS INC 2.7%
Value $35.43M Shares 2,857,143 Share Price $12.40 Est. Cost/Share $12.09 Unrealized @ Report Date —
— ENDOCYTE INC 2.7%
Value $35.28M Shares 3,881,793 Share Price $9.09 Est. Cost/Share $4.92 Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 2.7%
Value $35.11M Shares 2,472,344 Share Price $14.20 * Est. Cost/Share $12.78 Unrealized @ Report Date 0.0%
— KALA PHARMACEUTICALS INC 2.6%
Value $33.45M Shares 2,113,236 Share Price $15.83 Est. Cost/Share $22.84 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 2.6%
Value $33.32M Shares 6,984,692 Share Price $4.77 * Est. Cost/Share $7.39 Unrealized @ Report Date -30.5%
— RA PHARMACEUTICALS INC 1.6%
Value $20.45M Shares 3,851,808 Share Price $5.31 Est. Cost/Share $8.78 Unrealized @ Report Date —
— SOLID BIOSCIENCES INC 1.5%
Value $20.17M Shares 2,689,444 Share Price $7.50 Est. Cost/Share $7.50 Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 1.5%
Value $19.9M Shares 900,000 Share Price $22.11 * Est. Cost/Share $14.72 Unrealized @ Report Date +33.5%
— CLEARSIDE BIOMEDICAL INC 1.3%
Value $16.36M Shares 1,525,000 Share Price $10.73 Est. Cost/Share $10.73 Unrealized @ Report Date —
— AVEO PHARMACEUTICALS INC 1.1%
Value $14.68M Shares 5,062,759 Share Price $2.90 Est. Cost/Share $2.59 Unrealized @ Report Date —
KALV KALVISTA PHARMACEUTICALS INC 1.0%
Value $13.66M Shares 1,441,070 Share Price $9.48 * Est. Cost/Share $9.16 Unrealized @ Report Date +14.3%
— CATALYST BIOSCIENCES INC 1.0%
Value $13.29M Shares 514,917 Share Price $25.80 Est. Cost/Share $25.80 Unrealized @ Report Date —
IOVA IOVANCE BIOTHERAPEUTICS INC 0.9%
Value $11.14M Shares 659,059 Share Price $16.90 * Est. Cost/Share $15.14 Unrealized @ Report Date 0.0%
SPRO SPERO THERAPEUTICS INC 0.8%
Value $10.57M Shares 741,647 Share Price $14.25 * Est. Cost/Share $12.27 Unrealized @ Report Date -1.2%
— BIOHAVEN PHARMACTL HLDG CO LTD 0.7%
Value $9.367M Shares 363,636 Share Price $25.76 Est. Cost/Share $25.00 Unrealized @ Report Date —
VKTX VIKING THERAPEUTICS INC 0.7%
Value $8.868M Shares 2,029,396 Share Price $4.37 * Est. Cost/Share $5.53 Unrealized @ Report Date 0.0%
— SUNESIS PHARMACEUTICALS INC 0.5%
Value $6.722M Shares 2,471,456 Share Price $2.72 Est. Cost/Share $3.69 Unrealized @ Report Date —
KRYS KRYSTAL BIOTECH INC 0.4%
Value $5.005M Shares 496,071 Share Price $10.09 * Est. Cost/Share $10.08 Unrealized @ Report Date -2.2%
— GLYCOMIMETICS INC 0.3%
Value $4.115M Shares 253,547 Share Price $16.23 Est. Cost/Share $16.23 Unrealized @ Report Date —
— PROTEON THERAPEUTICS INC 0.3%
Value $3.344M Shares 1,337,462 Share Price $2.50 Est. Cost/Share $1.53 Unrealized @ Report Date —
— G1 THERAPEUTICS INC 0.1%
Value $1.482M Shares 40,000 Share Price $37.05 Est. Cost/Share $17.44 Unrealized @ Report Date —
— EDGE THERAPEUTICS INC 0.0%
Value $337K Shares 285,491 Share Price $1.18 Est. Cost/Share $1.18 Unrealized @ Report Date —
— CTI BIOPHARMA CORP 0.0%
Value $222K Shares 56,951 Share Price $3.90 Est. Cost/Share $3.90 Unrealized @ Report Date —